Wirkstoffe & Arzneimittelsicherheit

Quellenpassagen (1)

Nebenwirkungen · NovoNorm

NovoNorm 2 mg tablets · Abschnitt 4.8 · PDF-Seite 27

Immune system disorders Allergic reactions* Very rare Metabolism and nutrition Hypoglycaemia Common disorders Hypoglycaemic coma and Not known hypoglycaemic unconsciousness Eye disorders Refraction disorder* Very rare Cardiac disorders Cardiovascular disease Rare Gastrointestinal disorders Abdominal pain, diarrhoea Common Vomiting, constipation Very rare Nausea Not known Hepatobiliary disorders Abnormal hepatic function, Very rare increased liver enzymes* Skin and subcutaneous tissue Hypersensitivity* Not known disorders * see section Description of selected adverse reactions below

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.

Vollständigen Kontext in der EMA-Fachinformation lesen →

Quellennachweis

Version 2017-09-28T02:00:00Z · SHA-256 21f3e9a965985080da26b53db087c3ea5427f5ec520967dcb4970774d891373a · Passage 2063f7b198f0c2b8d47322cdc6e26751156832abd4f6482a0a492913ef24adf1 · Zeichen 626–1623 im Abschnitt

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.